Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Thorpe

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Behavioral Neuroscience|October 31, 2022
Impaired Morris water task retention following T21 light dark cycle exposure is not due to reduced hippocampal c-FOS expressionScott H Deibel, S Higdon, T T S Cassell, et al.
Molecular Pathology : MP|November 29, 2002
Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analysesJ R Batanian, L R Cavalli, N M Aldosari, et al.
Anaerobe|May 11, 2020
Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016D R Snydman, L A McDermott, S G Jenkins, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2019
U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016C M Thorpe, L A McDermott, M K Tran, et al.
Journal of Applied Microbiology|March 4, 2017
Selective method for identification and quantification of Bifidobacterium animalis subspecies lactis BB-12 (BB-12) from the gastrointestinal tract of healthy volunteers ingesting a combination probiotic of BB-12 and Lactobacillus rhamnosus GGD D Poutsiaka, I J Mahoney, L A McDermott, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2023
A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020-2021D R Snydman, L A McDermott, C M Thorpe, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Behavioral Neuroscience|October 31, 2022
Impaired Morris water task retention following T21 light dark cycle exposure is not due to reduced hippocampal c-FOS expressionScott H Deibel, S Higdon, T T S Cassell, et al.
Molecular Pathology : MP|November 29, 2002
Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analysesJ R Batanian, L R Cavalli, N M Aldosari, et al.
Anaerobe|May 11, 2020
Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016D R Snydman, L A McDermott, S G Jenkins, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2019
U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016C M Thorpe, L A McDermott, M K Tran, et al.
Journal of Applied Microbiology|March 4, 2017
Selective method for identification and quantification of Bifidobacterium animalis subspecies lactis BB-12 (BB-12) from the gastrointestinal tract of healthy volunteers ingesting a combination probiotic of BB-12 and Lactobacillus rhamnosus GGD D Poutsiaka, I J Mahoney, L A McDermott, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2023
A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020-2021D R Snydman, L A McDermott, C M Thorpe, et al.
Pageof 4